Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like Massachusetts Upstart Takes on Mighty Purdue Pharma Over Tougher-to-Abuse Opioids November 21, 2017 Veracyte Launches Campaign To Save Lives Through Early Screening For Lung Cancer September 18, 2017 Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies December 13, 2017
